While the relative level of AGO1 expression in MS patients was slightly higher compared to controls (p < 0.05), no significant differences were found between the study and control groups in the case of GEMIN4 (p > 0.05) (Figure 1). This evidence concerns the gene GEMIN4 and myeloid sarcoma.